Bank of America’s Genomic Health, Inc. GHDX Stock Holding History

Bank of America’s Portfolio GHDX Stock Details GHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-25,000	Closed	-$659K	–	8320
2014 Q1	$659K	Buy	+25,000	New	+$717K	﹤0.01%	4330

Bank of America's GHDX Position: Q4 2019 in Review

Bank of America sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 394,312 shares — an estimated $26.7M sold.

Bank of America first reported a position in GHDX in Q2 2013 and held it in 26 quarters. The position peaked at $26.7M in Q3 2019. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.

Bank of America reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
Bank of America sold 394,312 Genomic Health, Inc. shares in Q4 2019, an estimated $26.7M.
Bank of America first reported a position in Genomic Health, Inc. in Q2 2013 and held it in 26 quarters.
Bank of America's Genomic Health, Inc. position peaked at $26.7M in Q3 2019.
0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.

Based on Bank of America's 13F filing for Q4 2019, filed 14 Feb 2020.